Successful treatment of eltrombopag-resistant refractory immune thrombocytopenia with romiplostim

被引：0
|
作者：
Tomonori Nakazato
Chisako Ito
Ai Mihara
Yoshinobu Aisa
机构：
[1] Yokohama Municipal Citizen’s Hospital,Department of Hematology
来源：
International Journal of Hematology | 2013年 / 97卷
关键词：
Platelet Count; Danazol; Romiplostim; Eltrombopag; Immune Thrombocytopenia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：291 / 293
页数：2
相关论文
共 50 条
  • [21] Romiplostim for the treatment of primary immune thrombocytopenia
    Janssens, Ann
    EXPERT REVIEW OF HEMATOLOGY, 2012, 5 (02) : 133 - 144
  • [22] Predictive factors of response to eltrombopag and romiplostim in Egyptian immune thrombocytopenia patients: a single center experience
    El Demerdash, Doaa
    Mohamady, Nagham
    Abdelghany, Wafaa
    Youssef, Heba
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2023, 48 (01) : 88 - 93
  • [23] Efficacy and safety of eltrombopag in adult refractory immune thrombocytopenia
    Kim, Yeo-Kyeoung
    Lee, Seung-Sin
    Jeong, Sung-Hoon
    Ahn, Jae-Sook
    Yang, Deok-Hwan
    Lee, Je-Jung
    Kim, Hyeoung-Joon
    BLOOD RESEARCH, 2015, 50 (01) : 19 - 25
  • [24] Sequential Use of Romiplostim after Eltrombopag for Refractory Thrombocytopenia in Hydrocarbon-Induced Myelodysplasia
    Morales, Luis F.
    Miyara, Santiago J.
    Guevara, Sara
    Metz, Christine N.
    Shoaib, Muhammad
    Watt, Stacey
    Zafeiropoulos, Stefanos
    McCann-Molmenti, Alexia
    Hayashida, Kei
    Takegawa, Ryosuke
    Shinozaki, Koichiro
    Choudhary, Rishabh C.
    Brindley, Elena C.
    Nishikimi, Mitsuaki
    Kressel, Adam M.
    Alsalmay, Yaser M.
    Mazzotta, Elvio A.
    Cho, Young Min
    Aranalde, Gabriel, I
    Grande, Daniel A.
    Zanos, Stavros
    Becker, Lance B.
    Molmenti, Ernesto P.
    INTERNATIONAL JOURNAL OF ANGIOLOGY, 2021,
  • [25] Eltrombopag-based combination treatment for immune thrombocytopenia
    Gomez-Almaguer, David
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2018, 9 (10) : 309 - 317
  • [26] Initial romiplostim dosing and time to platelet response in patients with treatment refractory immune thrombocytopenia
    DasGupta, Ryan K.
    Levine, Lauren
    Wiczer, Tracy
    Cataland, Spero
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (03) : 567 - 576
  • [27] Spotlight on Eltrombopag in Treatment-Refractory Chronic Primary Immune Thrombocytopenia
    Karly P. Garnock-Jones
    BioDrugs, 2011, 25 : 401 - 404
  • [28] Efficacy and safety of eltrombopag in treatment-refractory primary immune thrombocytopenia: a retrospective study
    Eser, Ali
    Toptas, Tayfur
    Kara, Osman
    Sezgin, Aslihan
    Noyan-Atalay, Figen
    Yilmaz, Guven
    Ozgumus, Toluy
    Pepedil-Tanrikulu, Funda
    Kaygusuz-Atagunduz, Isik
    Firatli-Tuglular, Tulin
    BLOOD COAGULATION & FIBRINOLYSIS, 2016, 27 (01) : 47 - 52
  • [29] Platelet activation and function during eltrombopag treatment in immune thrombocytopenia
    Haselboeck, Johanna
    Pabinger, Ingrid
    Ay, Cihan
    Koder, Silvia
    Panzer, Simon
    ANNALS OF HEMATOLOGY, 2012, 91 (01) : 109 - 113
  • [30] Successful Use of Eltrombopag in a Young Child With Chronic Immune Thrombocytopenia
    Gruhn, Bernd
    Ehrnsperger, Achim
    Willy, Claudia
    Froehlich, Birgit
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (01)
12345